Unicycive Therapeutics Inc UNCY:NASDAQ

RT Quote | NASDAQ | USD
Last | 07/01/22 EDT
0.82quote price arrow down-0.01 (-1.2048%)
Volume
2,179
52 week range
0.62 - 8.73
Loading...
  • Open0.8328
  • Day High0.8328
  • Day Low0.82
  • Prev Close0.83
  • 52 Week High8.73
  • 52 Week High Date07/13/21
  • 52 Week Low0.62
  • 52 Week Low Date05/09/22

Key Stats

  • Market Cap12.32M
  • Shares Out15.03M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-60.19

KEY STATS

  • Open0.8328
  • Day High0.8328
  • Day Low0.82
  • Prev Close0.83
  • 52 Week High8.73
  • 52 Week High Date07/13/21
  • 52 Week Low0.62
  • 52 Week Low Date05/09/22
  • Market Cap12.32M
  • Shares Out15.03M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-60.19

RATIOS/PROFITABILITY

  • EPS (TTM)-0.86
  • P/E (TTM)-0.95
  • Fwd P/E (NTM)-0.90
  • EBITDA (TTM)-11.78M
  • ROE (TTM)-255.84%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/16/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Unicycive Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Unicycive Therapeutics, Inc. is a biotechnology company dedicated to developing treatments for certain medical conditions. The Company is focused on identifying medical conditions within and outside of kidney disease. Its development programs are focused on the development of two therapies: Renazorb, for treatment of hyperphosphatemia in patients with chronic kidney disease (CKD), and UNI 494, for treatment of acute kidney injury (AKI). Renazorb was initially developed by...
Address
4300 El Camino Real, Suite 210
Los Altos, CA
94022
United States

Top Peers

SYMBOLLASTCHG%CHG
NRBO
Neurobo Pharmaceuticals Inc
0.47-0.0098-2.0425%
GLMD
Galmed Pharmaceuticals Ltd
0.60-0.05-7.6923%
WINT
Windtree Therapeutics Inc
0.4265+0.0095+2.28%
ARTL
Artelo Biosciences Inc
0.31-0.0068-2.1465%
CYCC
Cyclacel Pharmaceuticals Inc
1.11+0.03+2.78%